A cOrticotropin antiserum was obtained from rabbits immunized with synthetic 1-24 corticotropin conjugated with bovine serum albumin.The antiserum did not cross react withsynthetica-melanotropin or withsynthetic/3-endorphin and had a cross reactivity of 0.23% with human f3-lipotropin. We developed a radioimmunoassay with the antiserumobtained, in which we used polyethyleneglycol inconjunction with a second precipitating antibody for fast (1 5-mm)separationof antibody-bound and free corticotropin. The assay had a sensitivity of 16 ng/L and was validated on patients with various pituitary and adrenal diseases. From 103 normal subjects, the median value for corticotropin
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Simultaneous measurement of plasma corticotropin (ACTH) and adrenal steroid amounts offers a more comprehensive assessment of pituitary-adrenal function than does measurement of steroid hormone alone. ACTH assay also could help differentiate primary and secondary hypercorticosteroidism. ACTH radioimmunoassay, practical for routine clinical use, was first published by Yalow et al.
(1) and Berson and Yalow (2) . In their reports, porcine ACTH at a dose of 25 units (Duracton; Nordic Biochemicals, Montreal, Canada) was used to immunize guinea pigs at irregular intervals. Among the 50 guinea pigs immunized, some produced excellent antisera and gave an assay sensitivity as high as 1 ng/L. Orth ( to conjugate porcine ACTH with rabbit serum albumin. The initial injection of conjugate was 3 mg, and the booster injection was 2mg (4) . Orth (3) modified the carbodiimide method by prolonging the reaction time from 30 mm to 8 hand maintaining the pH at 6.0 throughout the reaction to conjugate synthetic 1-24 ACTH with albumin. A dose of 1250 tg was used for the initial injection to immunize either sheep or rabbits, and 50-100 zg was used for the booster injection. Excellent antibody with high titer was produced three months after the initial injection. Despite this information and nearly 14 years of experience after the first paper was published, few clinical laboratories use the ACTH radioimmunoassay.
We report here our experience in producing and characterizing a clinically useful ACTH antiserum from one of six Cellulose dialysis tubing, 1 cm flat width, retains material with a relative molecular mass of 12 000 or more (Fisher Scientific Co., Chicago, IL 60143).
Materials and Methods
Reagents and Solutions
Potassium iodide solution. Dissolve 16 g of sucrose, 1 g of potassium iodide, and 20 mg of sodium azide in 100 mL of water.
Sodium metabi.sulfite solution for lactoperoxidase method. Dissolve 5 mg of sodium metabisulfite (Mallinckrodt) in 100 mL of phosphate buffer (10 mmol/L, pH 7.5) immediately before use.
Quso G-32 (Philadelphia Quartz Co., Philadelphia, PA 19481).
Acid-acetone
solution. To 40 mL of acetone, add a mixture of acetic acid and water (1/99 by vol) to give 100 mL and mix well.
Talcum-treated
human plasma. Mix 15 mL of agedhuman plasma (with sodium citrate as anticoagulant) from the blood bank with four 25-mg tablets of talcum (Ormont Drug and Chemical Co., Englewood, NJ 97631) for 1 h at room temperature and centrifuge (27 000 X g, 20 mm). Decant the supernate and save for future use.
Sodium barbital buffer, 20 mmol/L. Dissolve 3.68 g of sodium barbital and 7.85 mg of benzamidine.HCI in 900 mL of water, adjust the pH to 8.6 with 1 mol/L NaOH, add water to make volume 1.0 L, and store at 4 #{176}C.
Assay buffer. Dissolve mg of soybean trypsin inhibitor (Sigma) in 100 mL of barbital buffer.
Normal rabbit serum solution.
Dilute 0.8 mL of normal rabbit serum to 20.0 mL with barbital buffer.
Chloramine T solution: Dissolve 2.5 mg of Chloramine T (Eastman Kodak, Rochester, NY 14650) in 10 mL of phosphate buffer (0.5 mol/L, pH 7.5) immediately before use.
Sodium metabisulfite solution
for Chloramine T method. To the reaction mixture add 1 mL of talcum-treated plasma and 5 mg of Quso G-32; mix. Separate the Quso from the reaction mixture by centrifugation, wash with 3 mL of water, and elute with 0.5 mL of acid-acetone solution. To the acetone eluate, add 1.5 mL of water. Divide the acid-acetone-water mixture into 0.2-mL aliquots and store in the freezer. Chloramine T method: To 2.5 g of human ACTH inS 1sL of hydrochloric acid (5 mmolIL), add 25 zL of phosphate buffer (50 mmol/L, pH 7.5), 500 tCi of Na125!, and 2. Conjugation of synthetic ACTH. We conjugated synthetic 1-24 corticotropin (5 mg) with 5 mg of fatty acid-free bovine serum albumin by using 100 mg of 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide HC1. To monitor the percentage of corticotropin conjugated, we modified the method of McGuire et al. (4) by adding trace amounts of 125! labeled ACTH (32 000 cpm). The mixture was reacted for 30 mm at room temperature, transferred into 1-cm cellulose dialysis tubing, and dialysed for 48 h against 2 L of water with three changes; 32% of the radioactivity remained inside the dialysis bag. On the assumption that '251-labeled ACTH reacts with bovine serum albumin in a manner identical to that of 1-24 corticotropin, this indicates that 1.6 mg of the 5 mg of 1-24 corticotropin was conjugated with the albumin or that 8 mol of 1-24 corticotropin was conjugated with 1 mol of albumin.
Immunization of rabbits.
We dissolved 100 zg of conjugated 1-24 corticotropin in 1 mL of saline, homogenized it with 1 mL of complete Freund's adjuvant to form a thick emulsion, andinjected this intradermally at 30 sites on the backs of each of six 0.9-kg white, female New Zealand rabbits. Each rabbit received a monthly booster injection of 100 sg of conjugated ACTH and 1 mL of complete Freund's adjuvant in the same manner. Test bleeding was drawn 10 days after each booster injection. Three months after the initial injection, the rabbits were fed dexamethasone, 0.25 mg in 2.5 mL of elixir added to each 400 mL of drinking water. After six booster injections, one of the six rabbits produced an antiserum having a titer of 1:100 000 final dilution.
Sample preparation.
Ten milliliters of blood was drawn in an ice-cooled tube containing 1.0 mL of sodium citrate solution (38 g/L), and centrifuged immediately at 4 #{176}C to separate the plasma. The plasma was frozen at -20 #{176}C or packed in solid CO2 for shipping. Before assay, the plasma was thawed and recentrifuged at 35 000 X g for 10 mm to remove any precipitate that formed during storage.
Extraction of ACTH from tumor tissue. A piece of frozen tumor tissue was weighed and further cut with a surgical knife into small portions of 3 mm3 each. A homogenate in the proportion of 100 g/L was made by homogenizing the diced tissue in 0.1 mol/L acetic acid at 80 #{176}C in a homogenizer (Polytron; Kimematica, Lucerne, Switzerland) for 40 s at a setting of 4. We heated the homogenate in a boiling water bath for 10 mm to eliminate protease activity (7) and centrifuged it at 12 000 X g for 10 mm. The supernate was diluted with talcum-treated human plasma for assay. Assay procedure.
To duplicate sets of polystyrene tubes, 12 X 75 mm, add 0.5 mL of unextracted plasma or human ACTH standard (range 7.8 to 1000 pg) dissolved in 0.5 mL of talcum-treated plasma, 100 pL of labeled ACTH (containing 2000 cpm), and 1.9 mL of antiserum diluted (1:76 000) with assay buffer. For zero standard tubes, use 0.5 mL of talcumtreated plasma; for blank tubes, use 1.9 mL of assay buffer to replace the sample and diluted antiserum, respectively. Incubate all tubes at 4 #{176}C for four days. For separation of free and bound ACTH, add 375 tL of normal rabbit serum solution and 80 pL of goat antirabbit antiserum to each tube. Incubate the reaction for another 15 mm at room temperature; after adding 300 isL of polyethylene glycol (mol. wt. 6000), 200 g/L of water, centrifuge the tubes at 3000 X g for 20 mm at 4 #{176}C. Decant the supernate, and count the precipitate for 5 mm in an automatic gamma counter. Construct a standard curve of B/Bc, against the concentration of ACTH, and determine the concentration of ACTH in unknowns from this standard curve.
Results
lodination and Purification of Labeled ACTH
After iodination, either by the lactoperoxidase method or by the Chloramine T method, between 30 and 35% of the radioactivity added to the reaction mixture was recovered in the fraction of acid-acetone eluate. This fraction was diluted with water, divided into 0.2-mL aliquots, and stored in the freezer.
To ensure the quality of labeled ACTH for each assay, we mixed 0.2 mL of the aliquot with 1.8 mL of talcum-treated plasma; we further purified this mixture immediately before use on a CM-Sephadex column and eluted it with linear gradient ammonium acetate solutions (see Materials and Methods and Figure 1 ).
After elution we determined the trichioroacetic acid-precipitable radioisotope counts of the first and second peak. We found that 50% of the radioactive counts of the first peak and 100% of those of the second peak were precipitable, which indicates that at least 50% of the radioactive material in the Figure 1 shows the elution curve of ACTH one day after iodination. Fractions from the descending portion of the second peak were pooled and used as labeled ACTH for assay. The middle curve, done one week after iodination, shows an increase of the first peak. The lower curve, done four weeks after iodination, shows a further increase of the first peak, even though labeled ACTH aliquots were kept frozen. We found that, with CM-Sephadex purification before each assay, one batch of iodination product can be used for three or four weeks.
Cross Reactivities
The cross reactivities of this antiserum with synthetic a-melanotropin, synthetic /3-endorphin, and human f3-lipotropin were compared with that of human ACTH. The synthetic a-melanotropin, which is 1-13 ACTH, was determined at 1, 10, and 100 ng/tube; synthetic fl-endorphin, which is 61-91 /3-lipotropin, was determined at 100 ng, 1 sg, and 2 izg/tube. Neither substance showed detectable cross reactivity with the antiserum. At 1, 10, and 100 ng/tube, human f3-lipotropin showed a cross reactivity of about 0.23%, compared at midrange or ED5c, of the dose-response curves with human ACTH as cross reactivity of 100% (Figure 2 The same curve for /3-lipotropmn had a slope of -1.065 and an SD of 2.067 pg/tube. f3-Lipotropmn concentrations of 95 272, 12 108, and 1539 pg/tube gave logit B/Bc, of 10, 50, and 90, respectively.
Recovery Study
Human ACTH in amounts of 25, 50, and 100 pg was added to 0.5 mL of pooled patient's sample, and ACTH concentrations were determined by the assay. The recoveries were 100, 92, and 107% for 25, 50, and 100 pg of added ACTH, respectively ( Table 1) .
Assay Variation
A clinical sample was divided into aliquots and determined in three consecutive assays within a period of two weeks, with eight to 10 tubes in each assay. The ACTH values of individual tube determinations, the standard deviations, and the means within each assay determination are shown in Table 2 per tube before each assay as quality-control samples. Every assay, in addition to clinical quality-control samples, also includes two tubes of 100 pg of human ACTH plus 500 1.tLof talcum-treated human plasma. The results of 12 assays in a period of three months, as calculated by Rodbard's method (8) , are shown in Table 3 . The mean of duplicate tubes obtained from 12 assays was 103 pg/tube, the standard deviation between 12 assays was 10.97 pg/tube, and the coefficient of variation was 10.55%. The combined within-assay variance was 7.79 pg/tube, and the within-assay coefficient of variation was 7.56%.
Linearity of Results on Sample Dilution
A sample was diluted with talcum-treated plasma by twofold, fourfold, and eightfold. The undiluted sample and diluted samples were determined. The results were 800,405,210, and98pg, respectively. The weighted regression line of volume of sample vs. ACTH content passed through the origin (r = 0.996) (Figure 3 ). This suggested that samples at higher concentrations can be diluted to obtain an accurate value for their concentration. 
Determination of ACTH Content in Tumor Tissue
We homogenized an ACTH-producing tumor and extracted SD it with hot acetic acid, as described in Materials and Methods. (Figure 3 ), which suggests that the tumor extract may have contained some substance that slightly interfered with the assay. The assay, however, still can be used to estimate the ACTH content in a tumor. were 54 ± 27 ng/L for males, 51 ± 37 ng/L for females, and 51 ± 35 ng/L for females taking contraceptive pills. The difference among the groups was not statistically significant. The amount of corticosteroid in females taking contraceptive pills (380 ± 140 mg/L) was twice as high as that in normal males and females (160 ± 40 mg/L), but the ACTH values were not different. (In our laboratory, the normal range for morningdetermined corticosteroids is 70-280 mg/L.) On the second determination, we studied 42 males and 34 females. The results were 40 ± 38 ng/L for males and 34 ± 32 for females. The differences between males and females and between the first and second determinations were not significant. Thus, we pooled all the data to establish normal values for males and females. In all, 103 apparently healthy persons were studied, and the result was 41 ± 34 ng/L ( Table  4 ). The median of the 103 subjects was 34 ng/L and the upper 95% confidence limit of the normal range was 98 ng/L ( Figure  4) . 
Determination of ACTH in Normal and
Med
Primary hypercorticosteroidism (Cushing 's syndrome).
There were only three patients with primary hypercorticosteroidism treated in our clinic during the development of this assay. The first patient had ACTH-independent nodular hyperplasia of the adrenals. ACTH content, determined on separate days two weeks apart, was 26 and 0 ng/L. The second patient had one ACTH determination, 0 ng/L; later, a 21-g tumor was surgically removed from the left adrenal gland of this patient. The third patient had three ACTH determinations-0, 29, and 39 ng/L. A 2-to 3-g tumor was surgically removed from each side of the adrenal. The data indicated that low amounts of ACTH sometimes may be found in some patients with Cushing's syndrome (Figure 4 ).
Primary hypocorticosteroidism (Addison's disease).
Eight patients with defined Addison's disease had their ACTH amounts determined. Among them, four untreated patients had a higher median ACTH value than the four patients who were receiving replacement steroid. In one of the patients receiving replacement, ACTH values determined on different days were 26 and 32 ng/L (Figure 4) .
Enzymatic block or adrenogenital syndromes.
Eleven pediatric patients, all less than 13 years old, had a deficiency of either 17-or 21-hydroxylase. Four patients were without treatment, including one who had had no treatment for six months and whose ACTH values increased from 122 to 351 ng/L. Of seven patients with steroid treatment, one had an ACTH value of 85 ng/L before treatment and 10 ng/L after treatment (Figure 4) .
Ectopic ACTH syndrome. We studied six preoperative patients with ectopic ACTH syndrome caused by oat-cell carcinoma of the lung, medullary carcinoma of the thyroid gland, or pancreatic tumor. After resection of a 1-cm cystadenoma of the pancreas, one patient's ACTH decreased from 1280 to 20 ng/L (Figure 4 ). Ten months later, when the patient was rechecked, ACTH was determined to be 112 ng/L. The median value for patients with an ectopic ACTH syndrome who received surgical treatment was 70 ng/L and the range was 20-160 ng/L.
Cushing's disease (ACTH-dependent adrenal hyperplasia).
Of four patients with pituitary Cushing's disease but not operated on, two patients had determinations of ACTH repeated on different days. The results were 108, 108, 110, and 130 ng/L for one patient and 85,88, and 96 ngfL for the other. The mean and range for all four patients are given in Figure  5 . Their ACTH values were not too much higher than the average for normal subjects, but all had increased amounts of plasma corticosteroid. Three other patients with Cushing's disease had been successfully treated with radiation therapy to their pituitary glands; the median ACTH value was 14 ng/L, and the range was 10-17 ng/L ( Figure 5 ). Four patients with Cushing's disease had a remission induced by removal of pituitary tumor through a transsphenoidal approach; after the operation, their median ACTH value was 40 ng/L and the range was 10-74 ng/L.
Patients with pituitary-dependent Cushing's syndrome who were treated by adrenalectomy had a high tendency to develop Nelson's syndrome. Several of these patients, even without increasing pigmentation, had increases in ACTH ( Figure   5 ).
Nelson's syndrome
or increasing pigmentation after adrenalectomy. 
ACTH Change During Insulin Tolerance Test
This assay also can be used to monitor the change of ACTH secretion caused by insulin-induced hypoglycemia. Two patients with pituitary tumors had their blood sampled at 30-mm intervals after injection of insulin (0.15 U/kg of body wt). Both ACTH and corticosteroid values increased and reached their peak 60 mm after injection (Figure 6 ). At the peak, the corticosteroids and ACTH increased from basal values about 200% and 42%, respectively, for patient 1 and 160% and 54%, respectively, for patient 2. Recently, Lindholm et al. (9) showed that there was no significant correlation between ACTH and cortisol increase during insulin-induced hypoglycemia.
Discussion
The primary difficulty of the radioimmunoassay for ACTH is that normal subjects have very low amounts of ACTH in plasma, and hence a highly sensitive antiserum is required.
Production of highly sensitive antiserum against ACTH is difficult, primarily for two reasons: (a) ACTH is a relatively small molecule (mol. mass 4500), and the immunogenicity of molecules with a molecular mass of less than 10 000 is generally low; and (b) because no species difference is found in the biologically active sequence of 1-24 amino acid residues of ACTH (among its whole 39 residues), different species of ACTH used to immunize animals also may cause the adrenal gland to produce a large amount of cortisol, which inhibits the immunologic response.
E
To overcome these difficulties, with conjugated ACTH, which not only increased the immunogenicity but also decreased the biologic activity of ACTH after it was conjugated with albumin.
The dose of ACTH used for immunization in these suecessful reports was 1.25-3 mg per animal (2) (3) (4) . It is now believed that the antigen used for immunization should be highly pure and the dose should be small (10) . Vaitukaitis eta!. (11), in their work with human choriogonadotropin, reported that 100 tg was the smallest effective immunization dose that could produce antiserum in rabbits. For these reasons, we decided to use synthetic 1-24 corticotropin, which is pure, and injected a small amount of synthetic 1-24 corticotropinbovine serum albumin conjugate containing 100 zg of 1-24 corticotropin and 308 zg of bovine serum albumin (36 nmol and 4.5 nmol, respectively).
We used the same dose of conjugate for initial and booster injections. The labeled ACTH, which we added during the conjugation procedure, served as a conjugation indicator for calculating the amount of c#{243}nju-gate containing 100 tg of 1-24 corticotropin. With this immunization procedure, two of six rabbits after six booster injections produced antisera. One of the antisera, with a titer of 1:100 000 of the final dilution, was characterized and used for this clinical study. It did not cross react with a-melanotropin or with 3-endorphin and showed a cross reactivity of 0.23% with 3-lipotropin.
In our radioimmunoassay system, we did not find any significant difference in labeled ACTH produced by the Chloramine T or by the lactoperoxidase iodination method. Rae and Schimmer (12) also found that the biologic activity of labeled ACTH produced by the lactoperoxidase method was not necessarily better than that produced by the Chloramine T method. However, the labeled ACTH produeed by either method was further purified by ion-exchange column chromatography.
The method used to purify labeled ACTH for biologic studies (6) was modified; we used the CM-Sephadex column, which technically is easier to operate than the CMcellulose column, and a linear gradient of acetate solutions of 0.1-0.6 mol/L was at pH 6.0 instead of at pH 4.8.
The average specific activity of labeled ACTH prepared by either iodination method was 68 Ci/g of ACTH. At present, we cannot increase the specific activity without increasing the amount of damaged ACTH or decreasing the binding ability with antiserum. Based on this specific activity (68 Ci/g) and 60% counting efficiency for an average counter, 22 pg of labeled ACTH had a radioactivity of only 2000 cpm. To achieve a sensitivity of 16 ng/L in our assay, we used 2000 cpm of labeled ACTH per tube and counted every tube for 5 mm to accumulate a significant count. By doing so, we obtained a between-assay coefficient of variation of 10.55% (Table 3) , which is acceptable for general radioimmunoassay methods.
This indicates that, with care, 2000 cpm per tube can be used without unduly sacrificing the quality of the assay.
For economic reasons, we used benzamidine (13) and soy- (2). We did not find any significant protective function of mercaptoethanol in assay buffer, just as Orth (3) mentioned, and also deleted it from our assay buffer.
Some clinical samples have high lipid contents that will interfere with the ACTH assay and cause falsely high results. For this reason, we centrifuged all the clinical samples indiscriminately at 35 000 X g for 10 mm to remove the lipids.
The values for plasma ACTH determined in normal persons had a range comparable to that reported for radioimmunoassay of human ACTH (2, 14, 15 In some instances, multiple measurements tended to give a better correlation with the clinical situation. These are too few cases to present as a comprehensive clinical analysis. Yet, when other laboratories realize from using our technique that ACTH is not an impossible assay, more data will become available for evaluating the relationship between ACTH values and pituitary-adrenal problems.
